top of page

Ross Macdonald

Chief Commercial Officer

Dr Macdonald has over 34 years’ experience in pharmaceutical and biotechnology businesses. Most recently he was the CEO of Cynata Therapeutics Ltd, a cell therapy company that is pioneering the therapeutic use of iPSC-derived mesenchymal stem cells (MSCs).  His career history includes senior manaDr Macdonald has over 34 years’ experience in pharmaceutical and biotechnology businesses. Most recently he was the CEO of Cynata Therapeutics Ltd, a cell therapy company that is pioneering the therapeutic use of iPSC-derived mesenchymal stem cells (MSCs).  His career history includes senior management positions with a range of pharmaceutical and biopharma companies in Europe, the USA and Australia, primarily focussed on business development, corporate strategy and R&D management.  Dr Macdonald currently serves as a member of the Investment Committee of UniSeed Management Pty Ltd, an Australian venture capital company, a member of the commercialisation committee of the Florey Institute of Neuroscience and Mental Health and as a non-executive director of Trioda Wilingi Pty Ltd.gement positions with a range of pharmaceutical and biopharma companies in Europe, the USA and Australia, primarily focussed on business development, corporate strategy and R&D management.  Dr Macdonald currently serves as a member of the Investment Committee of UniSeed Management Pty Ltd, an Australian venture capital company, a member of the commercialisation committee of the Florey Institute of Neuroscience and Mental Health and as a non-executive director of Trioda Wilingi Pty Ltd.

Ross Macdonald
bottom of page